|
FluimediX participates in the CEMIK innovation contract along with leading research institutions and companies. (Risoe/DTU-nanotech, DTI, CCIT - Herlev Hospital, Smart Biosystems) The CEMIK consortia is exploring the use of microfluidic technologies in connection with cancer immune therapy (CCIT). FluimediX is providing knowledge on microfluidic handling as well as a novel tool used in connection with gene transfection.
FluimediX collaborates with "Sankt Hans Hospital" - the largest danish mental health facility. Sankt Hans is involved in foundational research within the field of pharmacogenetics.
|